OpenAlex
PricingAboutJobs
Log inGet started
Work

Brigatinib plus carboplatin–pemetrexed after lorlatinib failure in ALK-rearranged non-small cell lung cancer with co-occurring ALK I1171N and G1269A mutations: a case report

HTML

Year: 2026
Type: article
Study design: Case Report
Source: Journal of Chemotherapy
DOI: 10.1080/1120009x.2026.2762664
Authors: Fırat Akagündüz, Tugra Hakan Demir, Mustafa Alperen Tunc, Burak Pacacı, Ahmet Demirel, Erkam Kocaaslan, Ali Kaan Guren, Selver Isık, Abdussamet Celebi, Ezgi Coban, Nazım Can Demircan, Osman Kostek, Ibrahim Vedat Bayoglu, Murat Sarı
Institution: Marmara University
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: brigatinib, carboplatin, pemetrexed, ALK rearrangement, non-small cell lung cancer, lung adenocarcinoma, lorlatinib resistance, EML4-ALK fusion, cis-acting mutations, alectinib resistance, repeat biopsy, next-generation sequencing, maintenance therapy, metastatic disease
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W7234709756
FWCI:
Cites: 14
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security